Btw @friendlydwarves, fwiw, in 2017 ACR wrote down its Axiron IP to the tune of $10.7m. Ex this, the business would have made a net after-tax profit of $11.8m. Also in that year the business generated FCF of $4.7m. This was low due to a large tax payment in that year amounting to $6.3m - which did not match the actual tax expense for that year. The FCF before tax was $11m which well matches the P&L PBT (before IP impairments), which was $12m.
- Forums
- ASX - By Stock
- ACR
- Ann: Acrux's fifth generic dossier accepted by FDA for review
Ann: Acrux's fifth generic dossier accepted by FDA for review, page-21
-
- There are more pages in this discussion • 2 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add ACR (ASX) to my watchlist
|
|||||
Last
5.5¢ |
Change
0.000(0.00%) |
Mkt cap ! $15.98M |
Open | High | Low | Value | Volume |
5.6¢ | 5.6¢ | 5.5¢ | $11.36K | 203.1K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 25000 | 5.4¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
5.5¢ | 281819 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 25000 | 0.054 |
1 | 18800 | 0.053 |
2 | 36012 | 0.052 |
2 | 160000 | 0.051 |
4 | 737490 | 0.050 |
Price($) | Vol. | No. |
---|---|---|
0.055 | 281819 | 1 |
0.059 | 225945 | 1 |
0.060 | 123988 | 2 |
0.061 | 100000 | 1 |
0.062 | 116100 | 2 |
Last trade - 10.48am 11/09/2024 (20 minute delay) ? |
Featured News
ACR (ASX) Chart |